AmarinPlc Share Price (NASDAQ: AMRN)

$16.1

▲

0.45

(2.88%)

Live

Last updated on August 18, 2025 at 11:50 PM IST

$₹

Check the interactive AmarinPlc Stock chart to analyse performance

AmarinPlc stock performance

as on August 18, 2025 at 11:50 PM IST

Today's Low:$15.97
Today's High:$16.43
$16.10
0.81%
Downside
Day's Volatility :2.8%
Upside
2.01%
52 Weeks Low:$7.08
52 Weeks High:$17.49
$16.10
56.02%
Downside
52 Weeks Volatility :59.52%
Upside
7.95%

AmarinPlc Stock Returns

Period	Amarin Corp Plc	Sector (Health Care)	Index (Russel 2000)
3 Months	43.58%	2.3%	0.0%
6 Months	28.87%	-5.8%	0.0%
1 Year	17.67%	-10.9%	0.0%
3 Years	-50.47%	2.8%	-11.6%

Amarin Corp Plc Key Stats

Check AmarinPlc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$15.65
Open	$15.15
Today's High	$16.43
Today's Low	$15.97
Market Capitalization	$310.2M
Today's Volume	$81.5K
52 Week High	$17.49
52 Week Low	$7.08
Revenue TTM	$219.4M
EBITDA	$-48.3M
Earnings Per Share (EPS)	$-5.0
Profit Margin	-47.22%
Quarterly Earnings Growth YOY	-0.94%
Return On Equity TTM	-20.38%

Stock Returns calculator for AmarinPlc Stock including INR - Dollar returns

The AmarinPlc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

AmarinPlc investment value today

Current value as on today

₹1,25,126

Returns

₹25,126

(+25.13%)

Returns from AmarinPlc Stock

₹21,053 (+21.05%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards AmarinPlc Stock

18%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for AmarinPlc Stock from India on INDmoney has increased by 18% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Amarin Corp Plc

Name
Holdings %
Name
Holdings %
Waterfront Wealth Inc.
0.46%
Quinn Opportunity Partners LLC
0.28%
LCM Capital Management, Inc
0.21%
Resources Investment Advisors Inc
0.13%
Bleakley Financial Group LLC
0.11%
NJ State Employees Deferred Compnstin Pl
0.05%

Analyst Recommendation on AmarinPlc Stock

Rating

Trend

Sell

10%Buy

40%Hold

50%Sell

Based on 10 Wall street analysts offering stock ratings for AmarinPlc(by analysts ranked 0 to 5 stars)

AmarinPlc Share Price Target

What analysts predicted

Downside of 31.68%

Target:

$11.00

Current:

$16.10

AmarinPlc share price target is $11.00, a slight Downside of 31.68% compared to current price of $16.10 as per analysts' prediction.

AmarinPlc Stock Insights

Price Movement
In the last 3 months, AMRN stock has moved up by 47.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 42.01M → 46.61M (in $), with an average increase of 9.9% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -48.61M → -14.13M (in $), with an average increase of 110.4% per quarter
AMRN vs LLY (3 yr)
In the last 3 years, Eli Lilly And Company has given 5.9% return, outperforming this stock by 57.0%

Amarin Corp Plc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$429.8M	↑ 87.49%
Net Income	$-22.6M	↓ 80.55%
Net Profit Margin	-5.27%	↑ 45.53%

	FY20	Y/Y Change
Revenue	$614.1M	↑ 42.89%
Net Income	$-18.0M	↓ 20.51%
Net Profit Margin	-2.93%	↑ 2.34%

	FY21	Y/Y Change
Revenue	$583.2M	↓ 5.03%
Net Income	$7.7M	↓ 142.94%
Net Profit Margin	1.33%	↑ 4.26%

	FY22	Y/Y Change
Revenue	$369.2M	↓ 36.69%
Net Income	$-105.8M	↓ 1468.91%
Net Profit Margin	-28.66%	↓ 29.99%

	FY23	Y/Y Change
Revenue	$306.9M	↓ 16.87%
Net Income	$-59.1M	↓ 44.13%
Net Profit Margin	-19.26%	↑ 9.4%

	FY24	Y/Y Change
Revenue	$228.6M	↓ 25.51%
Net Income	$-82.2M	↑ 39.03%
Net Profit Margin	-35.95%	↓ 16.69%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$56.5M	↓ 25.05%
Net Income	$-10.0M	↑ 72.17%
Net Profit Margin	-17.62%	↓ 9.95%

	Q2 FY24	Q/Q Change
Revenue	$67.6M	↑ 19.62%
Net Income	$1.5M	↓ 115.29%
Net Profit Margin	2.25%	↑ 19.87%

	Q3 FY24	Q/Q Change
Revenue	$42.3M	↓ 37.4%
Net Income	$-25.1M	↓ 1751.38%
Net Profit Margin	-59.42%	↓ 61.67%

	Q4 FY24	Q/Q Change
Revenue	$62.3M	↑ 47.3%
Net Income	$-48.6M	↑ 93.44%
Net Profit Margin	-78.03%	↓ 18.61%

	Q1 FY25	Q/Q Change
Revenue	$42.0M	↓ 32.56%
Net Income	$-15.7M	↓ 67.71%
Net Profit Margin	-37.36%	↑ 40.67%

	Q2 FY25	Q/Q Change
Revenue	$46.6M	↑ 10.95%
Net Income	$-14.1M	↓ 9.93%
Net Profit Margin	-30.33%	↑ 7.03%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$333.7M	↑ 91.07%

	FY20	Y/Y Change
Profit	$482.6M	↑ 44.61%

	FY21	Y/Y Change
Profit	$461.9M	↓ 4.3%

	FY22	Y/Y Change
Profit	$242.5M	↓ 47.5%

	FY23	Y/Y Change
Profit	$165.5M	↓ 31.73%

	FY24	Y/Y Change
Profit	$81.4M	↓ 50.84%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$31.1M	↓ 30.49%

	Q2 FY24	Q/Q Change
Profit	$42.1M	↑ 35.12%

	Q3 FY24	Q/Q Change
Profit	$16.3M	↓ 61.3%

	Q4 FY24	Q/Q Change
Profit	$-9.6M	↓ 158.78%

	Q1 FY25	Q/Q Change
Profit	$25.1M	↓ 362.67%

	Q2 FY25	Q/Q Change
Profit	$50.4M	↑ 100.41%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-9.4M	↓ 90.11%
Investing Cash Flow	$-2.5M	↑ 4172.41%
Financing Cash Flow	$409.6M	↑ 51.01%

	FY20	Y/Y Change
Operating Cash Flow	$-21.7M	↑ 132.18%
Investing Cash Flow	$-377.0M	↑ 15112.39%
Financing Cash Flow	$-58.9M	↓ 114.38%

	FY21	Y/Y Change
Operating Cash Flow	$-66.5M	↑ 205.97%
Investing Cash Flow	$104.1M	↓ 127.62%
Financing Cash Flow	$-5.1M	↓ 91.39%

	FY22	Y/Y Change
Operating Cash Flow	$-180.1M	↑ 170.66%
Investing Cash Flow	$175.3M	↑ 68.38%
Financing Cash Flow	$-379.0K	↓ 92.53%

	FY23	Y/Y Change
Operating Cash Flow	$6.9M	↓ 103.82%
Investing Cash Flow	$-25.5M	↓ 114.56%
Financing Cash Flow	$230.0K	↓ 160.69%

	FY24	Y/Y Change
Operating Cash Flow	$-31.0M	↓ 550.87%
Investing Cash Flow	$-46.0M	↑ 80.14%
Financing Cash Flow	$-1.4M	↓ 727.39%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-12.6M	↑ 1832.86%
Investing Cash Flow	$28.7M	↓ 140.26%
Financing Cash Flow	$-1.4M	↓ 1817.09%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-2.8M	↓ 78.08%
Investing Cash Flow	$4.7M	↓ 83.55%
Financing Cash Flow	$32.7K	↓ 102.3%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-2.4M	↓ 14.7%
Investing Cash Flow	$-56.6M	↓ 1297.64%
Financing Cash Flow	$-67.6K	↓ 306.31%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-13.3M	↑ 465.13%
Investing Cash Flow	$-22.8M	↓ 59.76%
Financing Cash Flow	$17.0K	↓ 125.16%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-12.5M	↓ 6.39%
Investing Cash Flow	$12.1M	↓ 153.02%
Financing Cash Flow	$-1.1M	↓ 6682.35%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$16.6M	↓ 233.29%
Investing Cash Flow	$12.4M	↑ 2.87%
Financing Cash Flow	$-663.0K	↓ 40.75%

AmarinPlc Technicals Summary

Sell

Neutral

Buy

AmarinPlc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Amarin Corp Plc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Amarin Corp Plc	0.64%	28.87%	17.67%	-50.47%	-88.71%
Eli Lilly And Company	-8.0%	-18.2%	-23.93%	117.25%	360.46%
Johnson & Johnson	7.47%	13.97%	10.66%	4.33%	17.45%
Merck & Co. Inc.	6.18%	1.1%	-26.4%	-8.55%	-0.96%
Novo Nordisk A/s	-19.27%	-36.34%	-61.25%	0.26%	57.32%
Abbvie Inc	11.81%	5.32%	4.99%	45.71%	115.08%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Amarin Corp Plc	NA	NA	-1.74	0.2	-0.2	-0.04	NA	22.38
Eli Lilly And Company	45.86	45.86	1.01	22.82	0.86	0.17	0.01	20.38
Johnson & Johnson	18.69	18.69	1.06	10.85	0.3	0.08	0.03	32.6
Merck & Co. Inc.	12.98	12.98	0.83	8.93	0.35	0.13	0.04	19.57
Novo Nordisk A/s	13.37	13.37	1.54	24.84	0.79	0.22	0.03	37.82
Abbvie Inc	97.96	97.96	0.44	11.97	1.13	0.09	0.03	-0.1

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Amarin Corp Plc	Sell	$310.2M	-88.71%	NA	-47.22%
Eli Lilly And Company	Buy	$628.6B	360.46%	45.86	25.91%
Johnson & Johnson	Buy	$420.1B	17.45%	18.69	25.0%
Merck & Co. Inc.	Buy	$210.3B	-0.96%	12.98	25.79%
Novo Nordisk A/s	Buy	$226.3B	57.32%	13.37	35.61%
Abbvie Inc	Buy	$365.1B	115.08%	97.96	6.45%

About Amarin Corp Plc

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.

Organization	AmarinPlc
Employees	275
CEO	Mr. Aaron D. Berg
Industry	Health Technology

Key Management of Amarin Corp Plc

Name	Title
Mr. Aaron D. Berg	CEO, President & Director
Mr. Peter L. Fishman	Chief Financial Officer
Dr. Steven B. Ketchum Ph.D.	Executive VP, President of Research & Development and Chief Scientific Officer
Mr. Jonathan N. Provoost	Executive VP, Chief Legal & Compliance Officer and Secretary
Mr. Jordan Zwick	Senior VP of Corporate Business Development & Investor Relations
Mr. Laurent Abuaf	President of Europe & Senior VP
Dr. Nabil Abadir	Chief Medical Officer of Global Medical Affairs
Dr. David Keenan Ph.D.	Executive VP of Technical Operations & President of Europe

Important FAQs about investing in AMRN Stock from India :

What is AmarinPlc share price today?

AmarinPlc share price today is $16.10 as on August 18, 2025 at 11:50 PM IST. AmarinPlc share today touched a day high of $16.43 and a low of $15.97.

What is the 52 week high and 52 week low for AmarinPlc share?

AmarinPlc share touched a 52 week high of $17.49 and a 52 week low of $7.08. AmarinPlc stock price today, August 18, 2025 at 11:50 PM IST is trending at $16.10, lower by 7.95% versus the 52 week high.

How to invest in AmarinPlc Stock (AMRN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for AmarinPlc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AmarinPlc Shares that will get you 0.0932 shares as per AmarinPlc share price of $16.10 per share as on August 18, 2025 at 11:50 PM IST.

What is the minimum amount required to buy AmarinPlc Stock (AMRN) from India?

Indian investors can start investing in AmarinPlc (AMRN) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in AmarinPlc stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on AmarinPlc share’s latest price of $16.10 as on August 18, 2025 at 11:50 PM IST, you will get 0.6211 shares of AmarinPlc. Learn more about fractional shares .

What are the returns that AmarinPlc has given to Indian investors in the last 5 years?

AmarinPlc stock has given -88.71% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?